IHEvsSPDW
iShares U.S. Pharmaceuticals ETF against SPDR Portfolio Developed World ex-US ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IHE | SPDW | |
|---|---|---|
| Expense ratio | 0.40% | 0.030% |
| Assets | $1.6B | $40.8B |
| Net flow, 1 month | +$25M | — |
| Net flow, 1 year | +$795M | +$4.9B |
| Return, YTD | +16.3% | +13.8% |
| Return, 1 year | +30.5% | +15.9% |
| Avg daily volume | 177K | 2.6M |
| Holdings | 38 | 2480 |
| Listed | May 1, 2006 | Apr 20, 2007 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS